Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-10-31 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a company announcement dated October 31, 2016, detailing transactions related to Novozymes' share buy-back program. It includes specific data on the number of shares repurchased, transaction values, and detailed trading data. The content focuses on the company's repurchase of its own shares under a previously announced buy-back program. There is no indication of financial statements, earnings data, management discussion, or other report types. The document is not a report publication announcement but a detailed transaction report. Therefore, it fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2016-10-31 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 92% confidence The document describes Novozymes’ purchase of its own shares under a share buyback program, specifying the number of shares repurchased and total value. This is a Transaction in Own Shares announcement, matching code POS.
2016-10-31 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company managing its own shares, which corresponds to the 'Transaction in Own Shares' category. The document is very short (283 characters) and mentions reading the full announcement in PDF, but the core content is a direct report of a transaction (buyback), making POS more specific than RPA or RNS. The key phrase is 'stock buyback program' and 'purchased an accumulated... shares'.
2016-10-31 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program' by Novozymes, reporting the number of shares purchased, transaction values, and specific dates (October 24-28, 2016). This content directly relates to the company acquiring its own shares from the market. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on treasury share activity.
2016-10-31 English
Delårsrapport for de første 3 kvartaler af 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the first three quarters of 2016 for Novozymes. It contains detailed financial statements, performance analysis, segment reporting, and management commentary. It is clearly a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-10-26 English
Delårsrapport for de første 3 kvartaler af 2016
Earnings Release Classification · 85% confidence The document is a narrative trading update/earnings announcement in Danish summarizing key performance metrics for the first three quarters (organic sales changes, operating margin) and updated full‐year guidance. It does not present full financial statements or in‐depth tables, only headline metrics and outlook. This matches an Earnings Release (ER) rather than a comprehensive interim report. 9M 2016
2016-10-26 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.